𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy

✍ Scribed by D. M. A. Mann; R. Oliver; J. S. Snowden


Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
717 KB
Volume
85
Category
Article
ISSN
0001-6322

No coin nor oath required. For personal study only.

✦ Synopsis


The topographic distribution of brain atrophy was quantified by image analysis of fixed coronal brain slices from 12 patients dying with Huntington's disease (HD) and from 4 other patients dying with progressive supranuclear palsy (PSP). In HD, atrophy was maximal within the caudate nucleus, putamen and globus pallidus. However, the cerebral cortex was also atrophied with reductions in cross-sectional area within frontal, temporal and parietal lobes. In general, more white matter than grey matter was lost leading to an elevation in the grey/white matter ratio. The amygdala and thalamus were reduced in area. In PSP, lesser reductions in cortical area than those of HD were seen, these again being mostly due to a loss of white matter, resulting in an elevation of the grey/white ratio. The globus pallidus and thalamus were decreased in area, but no changes in the caudate nucleus and putamen were measured.


πŸ“œ SIMILAR VOLUMES


The topographic distribution of brain at
✍ D. M. A. Mann πŸ“‚ Article πŸ“… 1991 πŸ› Springer-Verlag 🌐 English βš– 674 KB

The extent of regional atrophy in ten patients, aged 52-74 years, dying with Alzheimer's disease uncomplicated pathologically by the effects of advanced old age or cerebrovascular disease, was quantified by image analysis of fixed coronal brain slices. Atrophy of the cerebral cortex was globally dis

Brain iron deposition fingerprints in Pa
✍ Kai Boelmans; Brigitte Holst; Marc Hackius; JΓΌrgen Finsterbusch; Christian Gerlo πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 944 KB

## Abstract It can be difficult to clinically distinguish between classical Parkinson's disease (PD) and progressive supranuclear palsy. Previously, there have been no biomarkers that reliably allow this distinction to be made. We report that an abnormal brain iron accumulation is a marker for ongo

Diagnostic accuracy of progressive supra
✍ Keith A. Josephs; Dennis W. Dickson πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 81 KB

## Abstract Diagnostic accuracy has been addressed previously for Parkinson's disease in a brain bank collection, but accuracy of progressive supranuclear palsy (PSP) has not been addressed in a similar setting. Clinical and genetic features of pathologically confirmed cases of PSP were compared wi

Joint and skeletal deformities in Parkin
✍ Ramsey Ashour; Joseph Jankovic πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 81 KB

## Abstract The objective of this study is to characterize clinical features of joint and skeletal deformities in Parkinson's disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP). Clinical information including age, gender, presence of deformity, initial symptom sid